- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04043039
Platelet Rich Fibrin in the Treatment of Full Thickness Palatal Wounds
March 14, 2023 updated by: Michele Paolantonio, G. d'Annunzio University
Platelet Rich Fibrin in the Treatment of Palatal Wounds After Full Thickness Palatal Grafts Harvesting: A Randomized Clinical Trial
In this study it will be investigated the usefulness of Platelet-Rich Fibrin (PRF) on in the full thickness palatal graft donor site healing acceleration and in the patient's morbidity reduction.
Eighty patients, with at least one gingival recession will be treated by a flap with connective tissue graft(CTG).
In the test group (20 patients) and in the control group 2 a quadruple layer of PRF membrane will be placed over the palatal wounds; conversely, the control groups 2-4 patients will be treated by an absorbable gelatin sponge.
Patients will be monitored at 1, 2, 3 and 4 weeks after surgery for the complete re-epithelialization of the palatal wound (CWE), the alteration of sensibility (AS) around the wound area, the post-operative discomfort (D), and the changes of feeding habits (CFH) by a visual analogic scale (VAS) evaluation.
Furthermore, the analgesics consumption and the existence of delayed bleeding from the palatal wound (DWB) during the first post-operative week will be assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this study it will be investigated the usefulness of Platelet-Rich Fibrin (PRF) on in the full thickness palatal graft donor site healing acceleration and in the patient's morbidity reduction.
Eighty patients, with at least one gingival recession will be treated by a coronally advanced flap (CAF) with connective tissue graft(CTG) resulting from the de-epithelialization of a free gingival graft.
In the test group (20 patients) a quadruple layer of PRF membrane will be placed over the palatal wounds; conversely, the control groups patients will be treated by an absorbable gelatin sponge.
Patients will be monitored at 1, 2, 3 and 4 weeks after surgery for the complete re-epithelialization of the palatal wound (CWE), the alteration of sensibility (AS) around the wound area, the post-operative discomfort (D), and the changes of feeding habits (CFH) by a visual analogic scale (VAS) evaluation.
Furthermore, the analgesics consumption and the existence of delayed bleeding from the palatal wound (DWB) during the first post-operative week will be assessed.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
CH
-
Chieti, CH, Italy, 66100
- G. d'Annunzio University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- to have a single gingival recession to be treated by a mucogingival surgery intervention
- to be in good systemic health
- to have a good oral hygiene
Exclusion Criteria:
- no systemic diseases; no coagulation disorders; no medications affecting periodontal status in the previous 6 months; no pregnancy or lactation;
- no smoking habits;
- no periodontal surgery on the experimental sites;
- no inadequate endodontic treatment
- no tooth mobility at the site of surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: FULL THICKNESS PALATAL GRAFT
the full thickness palatal wound will be protected by a quadruple layer of Platelet Rich Fibrin obtained by folding on itself 2 Platelet Rich Fibrin membrane or by gelatine sponge
|
palatal wound will be protected by a quadruple layer of Platelet Rich Fibrin obtained by folding on itself 2 Platelet Rich Fibrin membranes
palatal wound will be protected by gelatine sponge
|
Active Comparator: FREE GINGIVAL GRAFT
the Epithelialized Free Gingival Grafts palatal wound will be protected by a quadruple layer of Platelet Rich Fibrin obtained by folding on itself 2 Platelet Rich Fibrin membrane or by gelatine sponge
|
palatal wound will be protected by a quadruple layer of Platelet Rich Fibrin obtained by folding on itself 2 Platelet Rich Fibrin membranes
palatal wound will be protected by gelatine sponge
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time needed to obtain a complete re epithelialization of the palatal wound
Time Frame: 4 weeks
|
The primary outcome is to assess the time needed to obtain a complete re epithelialization of the palatal wound
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: michele paolantonio, università G. D'annunzio Chieti-Pescara
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 2, 2019
Primary Completion (Actual)
October 2, 2019
Study Completion (Actual)
November 4, 2019
Study Registration Dates
First Submitted
July 30, 2019
First Submitted That Met QC Criteria
August 1, 2019
First Posted (Actual)
August 2, 2019
Study Record Updates
Last Update Posted (Actual)
March 15, 2023
Last Update Submitted That Met QC Criteria
March 14, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 072019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Recession
-
Case Western Reserve UniversityRecruitingRecession, GingivalUnited States
-
University of LouisvilleRecruitingRecession, GingivalUnited States
-
Krishnadevaraya College of Dental Sciences & HospitalUnknown
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
British University In EgyptNot yet recruiting
-
SVS Institute of Dental SciencesCompleted
-
University of LouisvilleCompletedRecession, GingivalUnited States
-
Cairo UniversityUnknownRecession, Gingival
-
Botiss Medical AGCompletedRecession, GingivalSerbia
-
Luis Alberto Chauca BajañaUniversidad de GuayaquilNot yet recruitingGingival Recession | Gingival Recession, Localized
Clinical Trials on Palatal wound bandage with PRF
-
G. d'Annunzio UniversityUnknown
-
University of Alabama at BirminghamActive, not recruitingGingival Recession | Palate; WoundUnited States
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingInsulin | Wound Healing | Palate; WoundBrazil
-
Cairo UniversityUnknownSoft Tissue Augmentation
-
Pak Medical and Diagnostic CenterNot yet recruitingHair Loss/Baldness
-
OhioHealthNoxsano, Inc.TerminatedDiabetic Foot Ulcer | Peripheral Artery Disease | Wound Heal | Arterial Insufficiency | Ulcer Foot | Ulcer, LegUnited States
-
Izmir Katip Celebi UniversityCompleted
-
University of MichiganCompleted
-
University of Mogi das CruzesCompleted